nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Confusional state—Bleomycin—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Isotretinoin—Vision blurred—Carmustine—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Isotretinoin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000832	0.000832	CcSEcCtD
Isotretinoin—Tremor—Carmustine—lymphatic system cancer	0.00083	0.00083	CcSEcCtD
Isotretinoin—Oedema—Bleomycin—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Isotretinoin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Isotretinoin—Erythema—Mitoxantrone—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Isotretinoin—Infection—Bleomycin—lymphatic system cancer	0.000823	0.000823	CcSEcCtD
Isotretinoin—Anaemia—Carmustine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Isotretinoin—Back pain—Vincristine—lymphatic system cancer	0.000818	0.000818	CcSEcCtD
Isotretinoin—Vomiting—Teniposide—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Isotretinoin—Sepsis—Methotrexate—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Isotretinoin—Agitation—Carmustine—lymphatic system cancer	0.000814	0.000814	CcSEcCtD
Isotretinoin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Isotretinoin—Asthenia—Fludarabine—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Isotretinoin—Rash—Teniposide—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Isotretinoin—Dermatitis—Teniposide—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Isotretinoin—Headache—Teniposide—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Isotretinoin—Pruritus—Fludarabine—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Isotretinoin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Isotretinoin—Back pain—Mitoxantrone—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Isotretinoin—Anorexia—Bleomycin—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Isotretinoin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Isotretinoin—Anaemia—Vincristine—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Isotretinoin—Agitation—Vincristine—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Isotretinoin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Isotretinoin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Isotretinoin—Hypotension—Bleomycin—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Isotretinoin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Isotretinoin—Convulsion—Carmustine—lymphatic system cancer	0.000768	0.000768	CcSEcCtD
Isotretinoin—Hypertension—Carmustine—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Isotretinoin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Isotretinoin—Nausea—Teniposide—lymphatic system cancer	0.000763	0.000763	CcSEcCtD
Isotretinoin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Isotretinoin—Myalgia—Carmustine—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Isotretinoin—Chest pain—Carmustine—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Isotretinoin—Anxiety—Carmustine—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Isotretinoin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Isotretinoin—Malaise—Mitoxantrone—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Isotretinoin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Isotretinoin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Isotretinoin—Convulsion—Vincristine—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Isotretinoin—Hypertension—Vincristine—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Isotretinoin—Confusional state—Carmustine—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Isotretinoin—Oedema—Carmustine—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Isotretinoin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000722	0.000722	CcSEcCtD
Isotretinoin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00072	0.00072	CcSEcCtD
Isotretinoin—Myalgia—Vincristine—lymphatic system cancer	0.00072	0.00072	CcSEcCtD
Isotretinoin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Isotretinoin—Cough—Mitoxantrone—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Isotretinoin—Infection—Carmustine—lymphatic system cancer	0.000718	0.000718	CcSEcCtD
Isotretinoin—Vomiting—Fludarabine—lymphatic system cancer	0.000718	0.000718	CcSEcCtD
Isotretinoin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000714	0.000714	CcSEcCtD
Isotretinoin—Rash—Fludarabine—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Isotretinoin—Dermatitis—Fludarabine—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Isotretinoin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Isotretinoin—Pain—Bleomycin—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Isotretinoin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Isotretinoin—Headache—Fludarabine—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Isotretinoin—Tachycardia—Carmustine—lymphatic system cancer	0.000706	0.000706	CcSEcCtD
Isotretinoin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Isotretinoin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Isotretinoin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Isotretinoin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000699	0.000699	CcSEcCtD
Isotretinoin—Lethargy—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Isotretinoin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Isotretinoin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Isotretinoin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Isotretinoin—Oedema—Vincristine—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Isotretinoin—Anorexia—Carmustine—lymphatic system cancer	0.000689	0.000689	CcSEcCtD
Isotretinoin—Infection—Vincristine—lymphatic system cancer	0.000686	0.000686	CcSEcCtD
Isotretinoin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000683	0.000683	CcSEcCtD
Isotretinoin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Isotretinoin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Isotretinoin—Nervous system disorder—Vincristine—lymphatic system cancer	0.000677	0.000677	CcSEcCtD
Isotretinoin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Isotretinoin—Hypotension—Carmustine—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Isotretinoin—Oedema—Mitoxantrone—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Isotretinoin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Isotretinoin—Nausea—Fludarabine—lymphatic system cancer	0.000671	0.000671	CcSEcCtD
Isotretinoin—Infection—Mitoxantrone—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Isotretinoin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000667	0.000667	CcSEcCtD
Isotretinoin—Shock—Mitoxantrone—lymphatic system cancer	0.000661	0.000661	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000659	0.000659	CcSEcCtD
Isotretinoin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Isotretinoin—Urticaria—Bleomycin—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Isotretinoin—Anorexia—Vincristine—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Isotretinoin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Isotretinoin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000655	0.000655	CcSEcCtD
Isotretinoin—Insomnia—Carmustine—lymphatic system cancer	0.000654	0.000654	CcSEcCtD
Isotretinoin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000653	0.000653	CcSEcCtD
Isotretinoin—Irritability—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Isotretinoin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Isotretinoin—Paraesthesia—Carmustine—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Isotretinoin—Mood swings—Methotrexate—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Isotretinoin—Hypotension—Vincristine—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Isotretinoin—Dyspnoea—Carmustine—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Isotretinoin—Somnolence—Carmustine—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Isotretinoin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000641	0.000641	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000629	0.000629	CcSEcCtD
Isotretinoin—Decreased appetite—Carmustine—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Isotretinoin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Isotretinoin—Insomnia—Vincristine—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Isotretinoin—Paraesthesia—Vincristine—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Isotretinoin—Constipation—Carmustine—lymphatic system cancer	0.000618	0.000618	CcSEcCtD
Isotretinoin—Pain—Carmustine—lymphatic system cancer	0.000618	0.000618	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000614	0.000614	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000612	0.000612	CcSEcCtD
Isotretinoin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00061	0.00061	CcSEcCtD
Isotretinoin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Isotretinoin—Decreased appetite—Vincristine—lymphatic system cancer	0.0006	0.0006	CcSEcCtD
Isotretinoin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Isotretinoin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Isotretinoin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Isotretinoin—Fatigue—Vincristine—lymphatic system cancer	0.000595	0.000595	CcSEcCtD
Isotretinoin—Asthenia—Bleomycin—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Isotretinoin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000591	0.000591	CcSEcCtD
Isotretinoin—Pain—Vincristine—lymphatic system cancer	0.00059	0.00059	CcSEcCtD
Isotretinoin—Constipation—Vincristine—lymphatic system cancer	0.00059	0.00059	CcSEcCtD
Isotretinoin—Asthma—Methotrexate—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Isotretinoin—Pruritus—Bleomycin—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Isotretinoin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Isotretinoin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Isotretinoin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Isotretinoin—Pain—Mitoxantrone—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Isotretinoin—Constipation—Mitoxantrone—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Isotretinoin—Abdominal pain—Carmustine—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Isotretinoin—Body temperature increased—Carmustine—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Isotretinoin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000565	0.000565	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000564	0.000564	CcSEcCtD
Isotretinoin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000554	0.000554	CcSEcCtD
Isotretinoin—Dysuria—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Isotretinoin—Neutropenia—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00055	0.00055	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Isotretinoin—Body temperature increased—Vincristine—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Isotretinoin—Abdominal pain—Vincristine—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000538	0.000538	CcSEcCtD
Isotretinoin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Isotretinoin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000533	0.000533	CcSEcCtD
Isotretinoin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000531	0.000531	CcSEcCtD
Isotretinoin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000531	0.000531	CcSEcCtD
Isotretinoin—Pneumonia—Methotrexate—lymphatic system cancer	0.000528	0.000528	CcSEcCtD
Isotretinoin—Vomiting—Bleomycin—lymphatic system cancer	0.000527	0.000527	CcSEcCtD
Isotretinoin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000525	0.000525	CcSEcCtD
Isotretinoin—Drowsiness—Methotrexate—lymphatic system cancer	0.000525	0.000525	CcSEcCtD
Isotretinoin—Infestation—Methotrexate—lymphatic system cancer	0.000525	0.000525	CcSEcCtD
Isotretinoin—Depression—Methotrexate—lymphatic system cancer	0.000524	0.000524	CcSEcCtD
Isotretinoin—Rash—Bleomycin—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Isotretinoin—Dermatitis—Bleomycin—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000521	0.000521	CcSEcCtD
Isotretinoin—Asthenia—Carmustine—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Isotretinoin—Renal failure—Methotrexate—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Isotretinoin—Stomatitis—Methotrexate—lymphatic system cancer	0.000512	0.000512	CcSEcCtD
Isotretinoin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00051	0.00051	CcSEcCtD
Isotretinoin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000508	0.000508	CcSEcCtD
Isotretinoin—Sweating—Methotrexate—lymphatic system cancer	0.000503	0.000503	CcSEcCtD
Isotretinoin—Haematuria—Methotrexate—lymphatic system cancer	0.000501	0.000501	CcSEcCtD
Isotretinoin—Epistaxis—Methotrexate—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Isotretinoin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Isotretinoin—Asthenia—Vincristine—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Isotretinoin—Diarrhoea—Carmustine—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Isotretinoin—Nausea—Bleomycin—lymphatic system cancer	0.000492	0.000492	CcSEcCtD
Isotretinoin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Isotretinoin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000482	0.000482	CcSEcCtD
Isotretinoin—Dizziness—Carmustine—lymphatic system cancer	0.000478	0.000478	CcSEcCtD
Isotretinoin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000474	0.000474	CcSEcCtD
Isotretinoin—Diarrhoea—Vincristine—lymphatic system cancer	0.000472	0.000472	CcSEcCtD
Isotretinoin—Hepatitis—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Isotretinoin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Isotretinoin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000468	0.000468	CcSEcCtD
Isotretinoin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000465	0.000465	CcSEcCtD
Isotretinoin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000462	0.000462	CcSEcCtD
Isotretinoin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Isotretinoin—Vomiting—Carmustine—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Isotretinoin—Dizziness—Vincristine—lymphatic system cancer	0.000456	0.000456	CcSEcCtD
Isotretinoin—Rash—Carmustine—lymphatic system cancer	0.000456	0.000456	CcSEcCtD
Isotretinoin—Dermatitis—Carmustine—lymphatic system cancer	0.000455	0.000455	CcSEcCtD
Isotretinoin—Visual impairment—Methotrexate—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Isotretinoin—Headache—Carmustine—lymphatic system cancer	0.000453	0.000453	CcSEcCtD
Isotretinoin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000446	0.000446	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—lymphatic system cancer	0.00044	0.00044	CcSEcCtD
Isotretinoin—Tinnitus—Methotrexate—lymphatic system cancer	0.000439	0.000439	CcSEcCtD
Isotretinoin—Vomiting—Vincristine—lymphatic system cancer	0.000439	0.000439	CcSEcCtD
Isotretinoin—Rash—Vincristine—lymphatic system cancer	0.000435	0.000435	CcSEcCtD
Isotretinoin—Dermatitis—Vincristine—lymphatic system cancer	0.000435	0.000435	CcSEcCtD
Isotretinoin—Headache—Vincristine—lymphatic system cancer	0.000432	0.000432	CcSEcCtD
Isotretinoin—Nausea—Carmustine—lymphatic system cancer	0.000429	0.000429	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—lymphatic system cancer	0.000428	0.000428	CcSEcCtD
Isotretinoin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Isotretinoin—Rash—Mitoxantrone—lymphatic system cancer	0.000424	0.000424	CcSEcCtD
Isotretinoin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000423	0.000423	CcSEcCtD
Isotretinoin—Chills—Methotrexate—lymphatic system cancer	0.000423	0.000423	CcSEcCtD
Isotretinoin—Headache—Mitoxantrone—lymphatic system cancer	0.000421	0.000421	CcSEcCtD
Isotretinoin—Alopecia—Methotrexate—lymphatic system cancer	0.000417	0.000417	CcSEcCtD
Isotretinoin—Mental disorder—Methotrexate—lymphatic system cancer	0.000413	0.000413	CcSEcCtD
Isotretinoin—Malnutrition—Methotrexate—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Isotretinoin—Erythema—Methotrexate—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Isotretinoin—Nausea—Vincristine—lymphatic system cancer	0.00041	0.00041	CcSEcCtD
Isotretinoin—Nausea—Mitoxantrone—lymphatic system cancer	0.000399	0.000399	CcSEcCtD
Isotretinoin—Back pain—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—lymphatic system cancer	0.000387	0.000387	CcSEcCtD
Isotretinoin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000381	0.000381	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—lymphatic system cancer	0.000379	0.000379	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—lymphatic system cancer	0.00037	0.00037	CcSEcCtD
Isotretinoin—Cough—Methotrexate—lymphatic system cancer	0.000358	0.000358	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—lymphatic system cancer	0.000356	0.000356	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—lymphatic system cancer	0.000349	0.000349	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—lymphatic system cancer	0.000349	0.000349	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—lymphatic system cancer	0.000349	0.000349	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000347	0.000347	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—lymphatic system cancer	0.000345	0.000345	CcSEcCtD
Isotretinoin—Confusional state—Methotrexate—lymphatic system cancer	0.000338	0.000338	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000335	0.000335	CcSEcCtD
Isotretinoin—Infection—Methotrexate—lymphatic system cancer	0.000333	0.000333	CcSEcCtD
Isotretinoin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000328	0.000328	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000328	0.000328	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—lymphatic system cancer	0.000325	0.000325	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000324	0.000324	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—lymphatic system cancer	0.000319	0.000319	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—lymphatic system cancer	0.000313	0.000313	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000305	0.000305	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—lymphatic system cancer	0.000303	0.000303	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000301	0.000301	CcSEcCtD
Isotretinoin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000299	0.000299	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—lymphatic system cancer	0.000298	0.000298	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000295	0.000295	CcSEcCtD
Isotretinoin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000291	0.000291	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000289	0.000289	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—lymphatic system cancer	0.000289	0.000289	CcSEcCtD
Isotretinoin—Pain—Methotrexate—lymphatic system cancer	0.000286	0.000286	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000276	0.000276	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000274	0.000274	CcSEcCtD
Isotretinoin—Urticaria—Methotrexate—lymphatic system cancer	0.000266	0.000266	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000265	0.000265	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000265	0.000265	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000247	0.000247	CcSEcCtD
Isotretinoin—Asthenia—Methotrexate—lymphatic system cancer	0.00024	0.00024	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—lymphatic system cancer	0.000237	0.000237	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000229	0.000229	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—lymphatic system cancer	0.000221	0.000221	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—lymphatic system cancer	0.000213	0.000213	CcSEcCtD
Isotretinoin—Rash—Methotrexate—lymphatic system cancer	0.000211	0.000211	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—lymphatic system cancer	0.000211	0.000211	CcSEcCtD
Isotretinoin—Headache—Methotrexate—lymphatic system cancer	0.00021	0.00021	CcSEcCtD
Isotretinoin—Nausea—Methotrexate—lymphatic system cancer	0.000199	0.000199	CcSEcCtD
